# GlucoShield — Phase 7C Step 1 Recommendation & Feasibility Verdict
**Document ID:** `GLUCOSHIELD-RPT-PHASE7C-REC-001`  
**Timestamp:** 2026-08-28T17:20:00 Local Time  
**Author:** Lead Deep Learning & Physiological Systems Engineer  
**Status:** **FEASIBILITY AUDIT COMPLETE (V1 FROZEN & UNTOUCHED)**  

---

## 1. Executive Summary & Audit Findings

Phase 7C Step 1 evaluated candidate clinical datasets to determine whether synchronized continuous glucose monitoring (CGM) and wearable physical activity telemetry (Steps, Heart Rate, Accelerometer) from the same human participants can support **GlucoShield V2**.

### Key Audit Findings:
1. **OhioT1DM Dataset (Ohio University / KBR):**  
   * **Status:** Gold-standard benchmark for wearable diabetes research. Contains $12\text{ T1D patients}$ monitored 24/7 over **8 continuous weeks each** ($>650\text{ days}$ of dense co-recorded CGM, insulin, meals, steps, heart rate, skin temperature, and GSR).
   * **Access Requirement:** Free academic Data Use Agreement (DUA) requested via institutional email to Prof. Razvan Bunescu (`rbunescu@charlotte.edu`).
2. **D1NAMO Dataset (Hes-so Valais-Wallis):**  
   * **Status:** Open access benchmark on Zenodo (CC BY 4.0). Contains $9\text{ T1D patients}$ with co-recorded CGM and Zephyr BioHarness ECG/accelerometer telemetry over $4-5\text{ days}$.
3. **Shanghai Clinical Dataset (GlucoShield V1 Core):**  
   * **Status:** Open access baseline dataset ($N=112$). Contains zero physical activity or wearable telemetry.
4. **Physical Signal Feasibility:**  
   * Downsampling 5-minute steps and 1 Hz heart rate into a standardized **15-minute causal grid** (`steps_15m`, `hr_mean_15m`, `accel_mag_15m`, `active_load_60m`) is mathematically and computationally feasible without lookahead leakage.
5. **Architecture Staging Recommendation:**  
   * Deploy **Option A (Multimodal Neural Recurrent Extension)** as the initial validation baseline before considering an expanded 8-compartment exercise ODE (Option B) to avoid parameter identifiability risks.

---

## 2. Explicit Final Verdict

$$\mathbf{FINAL \; VERDICT: \quad B) \quad \text{PROCEED\_WITH\_RESTRICTED\_ACCESS\_REQUEST}}$$

### Operational Roadmap for Next Steps:
1. **Primary Track:** Prepare and submit the formal academic Data Use Agreement (DUA) request for the **OhioT1DM Dataset** (2018 + 2020 releases) to obtain the gold-standard 8-week longitudinal cohort.
2. **Exploratory Open Track (Parallel):** Utilize the open-access **D1NAMO dataset** on Zenodo to prototype and verify the 15-minute telemetry alignment and downsampling pipeline without waiting for DUA approval.
3. **Preservation Invariant:** GlucoShield V1 core models, checkpoints, and Phase 6 evaluation benchmarks remain bitwise locked and frozen.

---

## 3. Phase 7C Documentation Manifest (`research/phase7c/`)

* [`research/phase7c/WEARABLE_DATASET_AUDIT.md`](file:///D:/ML%20PROJECT/research/phase7c/WEARABLE_DATASET_AUDIT.md) — In-depth audit of OhioT1DM, D1NAMO, OpenAPS, and Shanghai cohorts.
* [`research/phase7c/DATASET_ACCESS_AND_SCHEMA_MATRIX.md`](file:///D:/ML%20PROJECT/research/phase7c/DATASET_ACCESS_AND_SCHEMA_MATRIX.md) — Strict feasibility matrix comparing access, cohort sizes, sampling, and suitability.
* [`research/phase7c/TELEMETRY_ALIGNMENT_FEASIBILITY.md`](file:///D:/ML%20PROJECT/research/phase7c/TELEMETRY_ALIGNMENT_FEASIBILITY.md) — Causal downsampling, clock sync, and missing-data strategy for 15-minute grid alignment.
* [`research/phase7c/ACTIVITY_FEATURE_SCIENTIFIC_AUDIT.md`](file:///D:/ML%20PROJECT/research/phase7c/ACTIVITY_FEATURE_SCIENTIFIC_AUDIT.md) — Scientific justification of 8 accepted features and explicit rejection of unfeasible signals.
* [`research/phase7c/V2_EXERCISE_ARCHITECTURE_OPTIONS.md`](file:///D:/ML%20PROJECT/research/phase7c/V2_EXERCISE_ARCHITECTURE_OPTIONS.md) — Comparative evaluation of Option A (Neural Extension) vs Option B (Exercise ODE Twin).
* [`research/phase7c/PHASE7C_STEP1_RECOMMENDATION.md`](file:///D:/ML%20PROJECT/research/phase7c/PHASE7C_STEP1_RECOMMENDATION.md) — Final executive report and explicit verdict.

---
*GlucoShield Phase 7C Step 1 Feasibility Audit Certified.*
